Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

BioSpecifics Technologies and Bausch & Lomb collaborate on glaucoma studies

June 27, 1997

Genistein prevents ischemic retinal degeneration in rats

June 25, 1997

Merck & Co. discloses muscarinic antagonists for myopia

June 20, 1997

Agents for glaucoma revealed by Merck & Co.

June 20, 1997

AEterna's IND for Neoretna approved in Canada

June 16, 1997

Retinal protein reduces need for standard drugs in uveitis

June 10, 1997

Oculex and Storz sign marketing agreement for ocular product

June 5, 1997

Monarch acquires ocular therapy from Glaxo Wellcome

May 30, 1997

Alphagan introduced in the U.K.

May 29, 1997

Short-acting beta1-adrenoceptor blockers from U. of Melbourne

May 27, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...